Persistent infection with human papillomavirus (HPV) initiates~ 5% of all human cancers,
and particularly cervical and oropharyngeal cancers. HPV vaccines prevent HPV infection …

Globally, human papilloma virus (HPV) infection is a common sexually transmitted disease.
However, most of the HPV infections eventually resolve aided by the body's efficient cell …

Carcinomas of the anogenital tract, in particular cervical cancer, remains one of the most
common cancers in women, and represent the most frequent gynecological malignancies …

Evasion of the host immune responses is critical for both persistent human papillomavirus
(HPV) infection and associated cancer progression. We have previously shown that …

Human papillomavirus (HPV) infection drives tumorigenesis in almost all cervical cancers
and a fraction of vulvar and penile cancers. Due to increasing incidence and low vaccination …

Actinic keratoses and cutaneous squamous cell carcinomas are associated with infections
with human papillomavirus of genus beta (betaHPV) in immunosuppressed patients. To …

Human papillomaviruses (HPVs) are small, double-stranded DNA viruses that replicate in
stratified squamous epithelia and cause a variety of malignancies. Current efforts in HPV …

Human papillomavirus (HPV)-mediated suppression of Langerhans cell (LC) function can
lead to persistent infection and development of cervical intraepithelial neoplasia (CIN) …

Recently, it has become clear that the tumour microenvironment (TME) is important in cancer
immunotherapy. While immune checkpoint inhibitors are effective for some patients, the …

Langerhans cells (LC) are skin-resident antigen-presenting cells that regulate immune
responses to epithelial microorganisms. Human papillomavirus (HPV) infection can promote …